Decentralized Clinical Trials in Oncology: Are We Ready for a Virtual-First Paradigm?
Fu, Sherry, Gerber, David E, Beg, Muhammad Shaalan
Published in Journal of clinical oncology (10.01.2023)
Published in Journal of clinical oncology (10.01.2023)
Get full text
Journal Article
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
Hellmann, Matthew D, Dr, Rizvi, Naiyer A, Prof, Goldman, Jonathan W, MD, Gettinger, Scott N, MD, Borghaei, Hossein, DO, Brahmer, Julie R, MD, Ready, Neal E, Prof, Gerber, David E, MD, Chow, Laura Q, MD, Juergens, Rosalyn A, MD, Shepherd, Frances A, Prof, Laurie, Scott A, MD, Geese, William J, PhD, Agrawal, Shruti, PhD, Young, Tina C, MS, Li, Xuemei, MD, Antonia, Scott J, Prof
Published in The lancet oncology (01.01.2017)
Published in The lancet oncology (01.01.2017)
Get full text
Journal Article
Emerging Strategies in Lung Cancer Screening: Blood and Beyond
Bhalla, Sheena, Yi, Sofia, Gerber, David E
Published in Clinical chemistry (Baltimore, Md.) (04.01.2024)
Published in Clinical chemistry (Baltimore, Md.) (04.01.2024)
Get full text
Journal Article
Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment
Pelosof, Lorraine C., MD, PhD, Gerber, David E., MD
Published in Mayo Clinic proceedings (01.09.2010)
Published in Mayo Clinic proceedings (01.09.2010)
Get full text
Journal Article
Pancreas patch grafting to treat type 1 diabetes
Yi, Xianwen, Xie, Youmei, Gerber, David A
Published in Biochemical and biophysical research communications (17.12.2023)
Published in Biochemical and biophysical research communications (17.12.2023)
Get full text
Journal Article
Development and Validation of a Nomogram Prognostic Model for SCLC Patients
Wang, Shidan, Yang, Lin, Ci, Bo, Maclean, Matthew, Gerber, David E., Xiao, Guanghua, Xie, Yang
Published in Journal of thoracic oncology (01.09.2018)
Published in Journal of thoracic oncology (01.09.2018)
Get full text
Journal Article
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer
Borghaei, Hossein, Gettinger, Scott, Vokes, Everett E, Chow, Laura Q M, Burgio, Marco Angelo, de Castro Carpeno, Javier, Pluzanski, Adam, Arrieta, Oscar, Frontera, Osvaldo Arén, Chiari, Rita, Butts, Charles, Wójcik-Tomaszewska, Joanna, Coudert, Bruno, Garassino, Marina Chiara, Ready, Neal, Felip, Enriqueta, García, Miriam Alonso, Waterhouse, David, Domine, Manuel, Barlesi, Fabrice, Antonia, Scott, Wohlleber, Markus, Gerber, David E, Czyzewicz, Grzegorz, Spigel, David R, Crino, Lucio, Eberhardt, Wilfried Enst Erich, Li, Ang, Marimuthu, Sathiya, Brahmer, Julie
Published in Journal of clinical oncology (01.03.2021)
Published in Journal of clinical oncology (01.03.2021)
Get full text
Journal Article
Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
Gettinger, Scott, Rizvi, Naiyer A, Chow, Laura Q, Borghaei, Hossein, Brahmer, Julie, Ready, Neal, Gerber, David E, Shepherd, Frances A, Antonia, Scott, Goldman, Jonathan W, Juergens, Rosalyn A, Laurie, Scott A, Nathan, Faith E, Shen, Yun, Harbison, Christopher T, Hellmann, Matthew D
Published in Journal of clinical oncology (01.09.2016)
Published in Journal of clinical oncology (01.09.2016)
Get full text
Journal Article